Quick Answer
BELITE BIO, INC reported Diluted EPS of $2.31 per share (loss) for fiscal year 2025.
BELITE BIO, INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.31 | -95.8% |
| 2024 | -$1.18 | +0.8% |
| 2023 | -$1.19 | -88.9% |
| 2022 | -$0.63 | +37.6% |
| 2021 | -$1.01 | -55.4% |
| 2020 | -$0.65 | — |
- BELITE BIO, INC showed a decrease of -95.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, BELITE BIO, INC’s diluted eps has declined by 255.4% (from $0.65 per share (loss) to $2.31 per share (loss)).
- The most recent figure is from BELITE BIO, INC’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: